Kevin McNamara - Chemed Pres CEO

CXM Stock

EUR 535.00 10.00 1.83%

Insider

Kevin McNamara is Pres CEO of Chemed

Age	69
Phone	513 762 6690
Web	https://www.chemed.com

Kevin McNamara Latest Insider Activity

Tracking and analyzing the buying and selling activities of Kevin McNamara against Chemed stock is an integral part of due diligence when investing in Chemed. Kevin McNamara insider activity provides valuable insight into whether Chemed is net buyers or sellers over its current business cycle. Note, Chemed insiders must abide by specific rules, including filing SEC forms every time they buy or sell Chemed'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

		Kevin McNamara over three weeks ago Acquisition by Kevin McNamara of 40332 shares of Chemed Corp at 597.7 subject to Rule 16b-3
		Kevin McNamara over three months ago Acquisition by Kevin McNamara of 40332 shares of Chemed Corp at 597.7 subject to Rule 16b-3
		Kevin McNamara over six months ago Disposition of 1500 shares by Kevin McNamara of Chemed Corp at 544.17 subject to Rule 16b-3
		Kevin McNamara over six months ago Acquisition by Kevin McNamara of 1081 shares of Chemed Corp at 586.49 subject to Rule 16b-3

Chemed Management Efficiency

The company has return on total asset (ROA) of 0.1558 % which means that it generated a profit of $0.1558 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3511 %, meaning that it generated $0.3511 on every $100 dollars invested by stockholders. Chemed's management efficiency ratios could be used to measure how well Chemed manages its routine affairs as well as how well it operates its assets and liabilities.

Compare Chemed to Peers

Predict price of Chemed

Chemed has accumulated 92.5 M in total debt with debt to equity ratio (D/E) of 30.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Chemed has a current ratio of 0.79, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Chemed until it has trouble settling it off, either with new capital or with free cash flow. So, Chemed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Chemed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Chemed to invest in growth at high rates of return. When we think about Chemed's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 10 records			INSIDER Age
	Meghan Cox	United States Steel	N/A
	Jessica Graziano	United States Steel	50
	James Bruno	United States Steel	57
	Kevin Lewis	United States Steel	N/A
	Steve Bugajski	United States Steel	N/A
	Manpreet Grewal	United States Steel	44
	David Burritt	United States Steel	68
	Christine CPM	United States Steel	67
	Kenneth Jaycox	United States Steel	55
	Duane Holloway	United States Steel	50

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio. CHEMED CORP operates under Medical Care classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15707 people. Chemed (CXM) is traded on Frankfurt Exchange in Germany and employs 14,167 people.

Management Performance

	Return On Equity	0.35
	Return On Asset	0.16

Chemed Leadership Team

Elected by the shareholders, the Chemed's board of directors comprises two types of representatives: Chemed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemed. The board's role is to monitor Chemed's management team and ensure that shareholders' interests are well served. Chemed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemed's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Thomas Hutton, VP Director
	Nicholas Westfall, Ex VP
	David Williams, Ex CFO
	Kevin McNamara, Pres CEO
	Sherri Warner, Director Relations
	Lisa Reinhard, Chief VP
	Brian Judkins, S VP

Chemed Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	0.35
	Return On Asset	0.16
	Profit Margin	0.12 %
	Operating Margin	0.16 %
	Current Valuation	7.54 B
	Shares Outstanding	14.95 M
	Shares Owned By Insiders	2.88 %
	Shares Owned By Institutions	95.31 %
	Price To Earning	32.25 X
	Price To Book	10.47 X

Currently Active Assets on Macroaxis

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation
BVHMF	Vistry Group PLC
S	SentinelOne

Other Information on Investing in Chemed Stock

Chemed financial ratios help investors to determine whether Chemed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chemed with respect to the benefits of owning Chemed security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC